Vera Jaber
Nurse Practitioner · Dearborn, MINPI 1871917724
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 254 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by Biogen at 30.7% of the total. Reporting peaked in 2021 at $1,201 and has fallen 62.2% since, to $454 in 2025. Among nurse practitioner clinicians in MI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 254 payments — averaging $16.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Biogen$1K
- UCB, Inc.$1K
- Harmony Biosciences LLC$381
- Neurelis, Inc.$240
- SK Life Science, Inc.$184
- Eisai Inc.$179
- plus $862 from 16 others
What the payments were for
- Food & beverage$4,296100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Biogen | 67 | $1,317 |
| UCB, Inc. | 94 | $1,133 |
| Harmony Biosciences LLC | 17 | $381 |
| Neurelis, Inc. | 11 | $240 |
| SK Life Science, Inc. | 8 | $184 |
| Eisai Inc. | 10 | $179 |
| EMD Serono, Inc. | 7 | $144 |
| Bristol Myers Squibb | 7 | $118 |
| AstraZeneca(2 entities) | 6 | $93 |
| Jazz Pharmaceuticals Inc. | 5 | $91 |
| AbbVie | 5 | $78 |
| Sumitomo Pharma America, Inc. | 4 | $66 |
| E.r. Squibb & Sons, L.L.C. | 2 | $56 |
| Johnson & Johnson | 2 | $55 |
| Vanda Pharmaceuticals Inc. | 2 | $40 |
| Alnylam Pharmaceuticals Inc. | 1 | $24 |
| Novartis | 1 | $21 |
| Tanabe Pharma America, Inc. | 1 | $19 |
| Supernus Pharmaceuticals, Inc. | 1 | $17 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| Amgen | 1 | $15 |
| Lilly USA, LLC | 1 | $13 |
How this compares
$4,296 in reported general payments places this provider in the 95th percentile of 3,351 nurse practitioner providers in Michigan.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 384 | $3,768 |
| Levetiracetam | 76 | $1,362 |
| Gabapentin | 76 | $727 |
| ClopidogrelClopidogrel Bisulfate | 121 | $682 |
| Pregabalin | 34 | $507 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 45 | $446 |
| Modafinil | 12 | $371 |
| Tizanidine Hcl | 30 | $301 |
| Baclofen | 30 | $298 |
| Clonazepam | 35 | $201 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 19 | $159 |
| Topiramate | 14 | $117 |
| Escitalopram Oxalate | 18 | $86 |
| Buspirone Hcl | 15 | $76 |
| Tramadol Hcl | 12 | $54 |
Paid to pharmacies, not to this prescriber.
Other nurse practitioner in Dearborn
- Abubakir BabanDearborn$143K
- Karen GagnonDearborn$10K
- Davida KrugerDetroit$739K
- Kari HillSpring Lake$426K
- Kyle FarrPlymouth$243K
- Linda SpencerTroy$217K
- Ellen DillardDetroit$168K
- Golbon AghamohammadiDetroit$157K
- Lisa Astalos ChismWoodhaven$103K
- Martha GoetzPetoskey$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.